Vas Narasimhan, Novartis CEO (Chris J. Ratcliffe/Bloomberg via Getty Images) July 21, 2026 11:41 AM EDT R&DPharma For Novartis' CEO, China deals aren't a strategy shift — just where the science is Ayisha Sharma News Reporter Novartis isn’t making deals in China just for the sake of buying there. That’s the word from CEO Vas Narasimhan, who told reporters on a … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
96 words · extracted 3h agoread original ↗
comments(0)
5-min edit window · permanent after that